Yuhan Corporation
000100Pharmaceuticals
₩74,700.00−3.36%As of Oct 29vs prior close
- Market cap
- $4.1B
- P/E (TTM)
- 23.5×
- P/E (FY1)
- 36.7×
- From 52W high
- −39.92%
- EPS (LTM)
- ₩3,179.94
- Revenue (LTM)
- ₩2.3T
- Net margin
- 10.39%
- Dividend yield
- 0.80%
Nomior Score
21
Steady ProfileBottom 8% of the scored universe
Growth56
Quality42
Value26
Momentum4
Resilience44
Growth
+7.18%revenue a year over 3 fiscal years
YE22 ₩1.8TLTM ₩2.3T
Connections
Revenue to profitYE25
9% of revenue became net profit, up 5 pts on a year.